Table 3.

Beta cell function (measured with HOMA Model Assessment [19], and T2DM risk measured with the risk score developed by Stern et al. [21] and prevalence of the metabolic syndrome (according to ATPIII criteria [20] in NGT and subjects with prediabetes diagnosed with the OGTT and HbA1c

	HbA1c Criteria			OGTT Criteria
	Normal	Prediabetes	P-Value	Normal	Prediabetes	P-Value
Number	246	200		150	296
Beta Cell Function	42 ± 1	37 ± 1	0.001	53 ± 2	33 ± 1	< 0.0001
% With MS	44	49	NS	20	60	< 0.0001
Future T2DM Risk Score	12.9 ± 0.8	19.3 ± 1.2	< 0.0001	8.8 ± 0.5	19.3 ± 1.1	< 0.0001

MS metabolic syndrome